100 related articles for article (PubMed ID: 18049476)
1. Che-1 activates XIAP expression in response to DNA damage.
Bruno T; Iezzi S; De Nicola F; Di Padova M; Desantis A; Scarsella M; Di Certo MG; Leonetti C; Floridi A; Passananti C; Fanciulli M
Cell Death Differ; 2008 Mar; 15(3):515-20. PubMed ID: 18049476
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
[TBL] [Abstract][Full Text] [Related]
3. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB-dependent regulation of brain-derived neurotrophic factor in hippocampal neurons by X-linked inhibitor of apoptosis protein.
Kairisalo M; Korhonen L; Sepp M; Pruunsild P; Kukkonen JP; Kivinen J; Timmusk T; Blomgren K; Lindholm D
Eur J Neurosci; 2009 Sep; 30(6):958-66. PubMed ID: 19735291
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line.
Wang R; Li B; Wang X; Lin F; Gao P; Cheng SY; Zhang HZ
Auris Nasus Larynx; 2009 Jun; 36(3):332-9. PubMed ID: 19013033
[TBL] [Abstract][Full Text] [Related]
6. Che-1/AATF, a multivalent adaptor connecting transcriptional regulation, checkpoint control, and apoptosis.
Passananti C; Floridi A; Fanciulli M
Biochem Cell Biol; 2007 Aug; 85(4):477-83. PubMed ID: 17713582
[TBL] [Abstract][Full Text] [Related]
7. Essential postmitochondrial function of p53 uncovered in DNA damage-induced apoptosis in neurons.
Vaughn AE; Deshmukh M
Cell Death Differ; 2007 May; 14(5):973-81. PubMed ID: 17218959
[TBL] [Abstract][Full Text] [Related]
8. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
[TBL] [Abstract][Full Text] [Related]
9. DNA damage signaling recruits the RNA polymerase II binding protein Che-1 to the p53 promoter.
Halazonetis TD; Bartek J
Mol Cell; 2006 Dec; 24(6):809-10. PubMed ID: 17189183
[TBL] [Abstract][Full Text] [Related]
10. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint.
Bruno T; De Nicola F; Iezzi S; Lecis D; D'Angelo C; Di Padova M; Corbi N; Dimiziani L; Zannini L; Jekimovs C; Scarsella M; Porrello A; Chersi A; Crescenzi M; Leonetti C; Khanna KK; Soddu S; Floridi A; Passananti C; Delia D; Fanciulli M
Cancer Cell; 2006 Dec; 10(6):473-86. PubMed ID: 17157788
[TBL] [Abstract][Full Text] [Related]
11. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
[TBL] [Abstract][Full Text] [Related]
12. Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation.
Nakano Y; Bilim V; Yuuki K; Muto A; Kato T; Nagaoka A; Tomita Y
Prostate Cancer Prostatic Dis; 2009; 12(1):34-40. PubMed ID: 18475287
[TBL] [Abstract][Full Text] [Related]
13. Che-1: a new effector of checkpoints signaling.
Floridi A; Fanciulli M
Cell Cycle; 2007 Apr; 6(7):804-6. PubMed ID: 17377493
[TBL] [Abstract][Full Text] [Related]
14. The association of up-regulation of X-linked inhibitor of apoptosis protein with cell adhesion-mediated drug resistance in U937 cells.
Wang X; Wang C; Qin YW; Yan SK; Gao YR
Hematol Oncol; 2008 Mar; 26(1):21-6. PubMed ID: 17721914
[TBL] [Abstract][Full Text] [Related]
15. The novel phospholipase C activator, m-3M3FBS, induces apoptosis in tumor cells through caspase activation, down-regulation of XIAP and intracellular calcium signaling.
Jung EM; Lee TJ; Park JW; Bae YS; Kim SH; Choi YH; Kwon TK
Apoptosis; 2008 Jan; 13(1):133-45. PubMed ID: 18060503
[TBL] [Abstract][Full Text] [Related]
16. Effective enhancement of X-ray-induced apoptosis in human cancer cells with mutated p53 by siRNA targeting XIAP.
Ohnishi K; Nagata Y; Takahashi A; Taniguchi S; Ohnishi T
Oncol Rep; 2008 Jul; 20(1):57-61. PubMed ID: 18575718
[TBL] [Abstract][Full Text] [Related]
17. CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner.
Huang J; Yang M; Liu H; Jin J
Food Chem Toxicol; 2009 Jan; 47(1):40-9. PubMed ID: 18761050
[TBL] [Abstract][Full Text] [Related]
18. NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death.
Di Certo MG; Corbi N; Bruno T; Iezzi S; De Nicola F; Desantis A; Ciotti MT; Mattei E; Floridi A; Fanciulli M; Passananti C
J Cell Sci; 2007 Jun; 120(Pt 11):1852-8. PubMed ID: 17488777
[TBL] [Abstract][Full Text] [Related]
19. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Cillessen SA; Hess CJ; Hooijberg E; Castricum KC; Kortman P; Denkers F; Vos W; van de Wiel MA; Schuurhuis GJ; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
Clin Cancer Res; 2007 Dec; 13(23):7012-21. PubMed ID: 18056177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
